Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Substantia Nigra »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Substance-Related Disorders < Substantia Nigra < Subthalamic Nucleus  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 269.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000001 (1999) A E Kingsbury [Royaume-Uni] ; C D Marsden ; O J FosterThe vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: an in situ hybridization study.
000036 (1999) E C Hirsch ; S. Hunot ; B. Faucheux ; Yves Agid [France] ; Y. Mizuno ; H. Mochizuki ; W G Tatton ; N. Tatton ; W C OlanowDopaminergic neurons degenerate by apoptosis in Parkinson's disease.
000042 (1999) M. Neystat [États-Unis] ; T. Lynch ; S. Przedborski ; N. Kholodilov ; M. Rzhetskaya ; R E BurkeAlpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.
000100 (1999) P J Bédard [Canada] ; P J Blanchet ; D. Lévesque ; J J Soghomonian ; R. Grondin ; M. Morissette ; M. Goulet ; F. Calon ; P. Falardeau ; B. Gomez-Mancilla ; J P Doucet ; G S Robertson ; T. DipaoloPathophysiology of L-dopa-induced dyskinesias.
000158 (1999) F. Cardozo-Pelaez [États-Unis] ; S. Song ; A. Parthasarathy ; C. Hazzi ; K. Naidu ; J. Sanchez-RamosOxidative DNA damage in the aging mouse brain.
000163 (1999) I. Vermes [Pays-Bas] ; E N Steur ; C. Reutelingsperger ; C. HaanenDecreased concentration of annexin V in parkinsonian cerebrospinal fluid: speculation on the underlying cause.
000164 (1999) G. Ebersbach [Autriche] ; M. Stöck ; J. Müller ; G. Wenning ; J. Wissel ; Werner Poewe [Autriche]Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration.
000183 (2000) L V Metman ; S. Konitsiotis ; T N ChasePathophysiology of motor response complications in Parkinson's disease: hypotheses on the why, where, and what.
000232 (2000) M. Bhatt [Inde] ; J. Desai ; A. Mankodi ; M. Elias ; N. WadiaPosttraumatic akinetic-rigid syndrome resembling Parkinson's disease: a report on three patients.
000268 (2000) D A Di Monte [États-Unis] ; A. Mccormack ; G. Petzinger ; A M Janson ; M. Quik ; W J LangstonRelationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
000318 (2000) R E Tabamo [États-Unis] ; H H Fernandez ; J H Friedman ; D K SimonYoung-onset Parkinson's disease: a clinical pathologic description of two siblings.
000328 (2000) M. Rodríguez [Espagne] ; P. Abdala ; J A ObesoExcitatory responses in the 'direct' striatonigral pathway: effect of nigrostriatal lesion.
000341 (2000) S. Hayashi [Japon] ; K. Wakabayashi ; A. Ishikawa ; H. Nagai ; M. Saito ; M. Maruyama ; T. Takahashi ; T. Ozawa ; S. Tsuji ; H. TakahashiAn autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene.
000349 (2000) L. Vercueil [France] ; A. Hammouti ; M L Andriantseheno ; M. Mohr ; C. Tranchant ; P. Maquet ; C. Marescaux ; F. SellalPallido-Luysio-Nigral atrophy revealed by rapidly progressive hemidystonia: a clinical, radiologic, functional, and neuropathologic study.
000354 (2000) S. Aime [Italie] ; B. Bergamasco ; M. Casu ; G. Digilio ; M. Fasano ; S. Giraudo ; L. LopianoIsolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.
000373 (2000) S H Fox [Royaume-Uni] ; J M Brotchie5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease.
000429 (2001) A J Grau [Allemagne] ; V. Willig ; W. Fogel ; E. WerleAssessment of plasma lactoferrin in Parkinson's disease.
000437 (2001) C S Lu [Taïwan] ; J C Wu ; C H Tsai ; R S Chen ; Y H Chou ; N. Hattori ; H. Yoshino ; Y. MizunoClinical and genetic studies on familial parkinsonism: the first report on a parkin gene mutation in a Taiwanese family.
000458 (2001) H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C HirschCaspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000460 (2001) A. Albanese [Italie] ; U. Bonuccelli ; C. Brefel ; K R Chaudhuri ; C. Colosimo ; T. Eichhorn ; E. Melamed ; P. Pollak ; T. Van Laar ; M. ZappiaConsensus statement on the role of acute dopaminergic challenge in Parkinson's disease.
000483 (2001) S. Goldstein [États-Unis] ; J H Friedman ; R. Innis ; J. Seibyl ; K. MarekHemi-parkinsonism due to a midbrain arteriovenous malformation: dopamine transporter imaging.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Substantia Nigra" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Substantia Nigra" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Substantia Nigra
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024